| L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials GI Papakostas, RC Shelton, JM Zajecka, B Etemad, K Rickels, A Clain, ... American Journal of Psychiatry 169 (12), 1267-1274, 2012 | 341 | 2012 |
| Associations of carotid artery intima‐media thickness (IMT) with risk factors and prevalent cardiovascular disease: comparison of mean common carotid artery IMT with maximum … JF Polak, MJ Pencina, A Meisner, KM Pencina, LS Brown, PA Wolf, ... Journal of ultrasound in medicine 29 (12), 1759-1768, 2010 | 190 | 2010 |
| Adjustment of the GRACE score by growth differentiation factor 15 enables a more accurate appreciation of risk in non-ST-elevation acute coronary syndrome C Widera, MJ Pencina, A Meisner, T Kempf, K Bethmann, I Marquardt, ... European heart journal 33 (9), 1095-1104, 2012 | 129 | 2012 |
| CD4 helper T cells, CD8 cytotoxic T cells, and FOXP3+ regulatory T cells with respect to lethal prostate cancer S Davidsson, AL Ohlson, SO Andersson, K Fall, A Meisner, M Fiorentino, ... Modern pathology 26 (3), 448-455, 2013 | 115 | 2013 |
| Modification of the Association Between Obesity and Lethal Prostate Cancer by TMPRSS2:ERG A Pettersson, RT Lis, A Meisner, R Flavin, EC Stack, M Fiorentino, S Finn, ... Journal of the National Cancer Institute 105 (24), 1881-1890, 2013 | 97 | 2013 |
| Combined utility of 25 disease and risk factor polygenic risk scores for stratifying risk of all-cause mortality A Meisner, P Kundu, YD Zhang, LV Lan, S Kim, D Ghandwani, ... The American Journal of Human Genetics 107 (3), 418-431, 2020 | 56 | 2020 |
| A repeated measures model for analysis of continuous outcomes in sequential parallel comparison design studies G Doros, M Pencina, D Rybin, A Meisner, M Fava Statistics in medicine 32 (16), 2767-2789, 2013 | 52 | 2013 |
| Developing risk prediction models for kidney injury and assessing incremental value for novel biomarkers KF Kerr, A Meisner, H Thiessen-Philbrook, SG Coca, CR Parikh Clinical Journal of the American Society of Nephrology 9 (8), 1488-1496, 2014 | 42 | 2014 |
| Apolipoprotein E/C1 locus variants modify renal cell carcinoma risk LE Moore, P Brennan, S Karami, I Menashe, SI Berndt, LM Dong, ... Cancer research 69 (20), 8001-8008, 2009 | 38 | 2009 |
| Androgen Receptor CAG Repeat Polymorphism and Risk of TMPRSS2:ERG–Positive Prostate Cancer S Yoo, A Pettersson, KM Jordahl, RT Lis, S Lindstrom, A Meisner, ... Cancer Epidemiology, Biomarkers & Prevention 23 (10), 2027-2031, 2014 | 34 | 2014 |
| A 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial of ziprasidone as monotherapy for major depressive disorder GI Papakostas, OV Vitolo, WW IsHak, MH Rapaport, JM Zajecka, G Kinrys, ... The Journal of clinical psychiatry 73 (12), 22318, 2012 | 33 | 2012 |
| Evaluating biomarkers for prognostic enrichment of clinical trials KF Kerr, J Roth, K Zhu, H Thiessen-Philbrook, A Meisner, FP Wilson, ... Clinical Trials 14 (6), 629-638, 2017 | 30 | 2017 |
| A Single Nucleotide Polymorphism in Inflammatory Gene RNASEL Predicts Outcome after Radiation Therapy for Localized Prostate Cancer JD Schoenfeld, DN Margalit, JL Kasperzyk, IM Shui, JR Rider, ... Clinical Cancer Research 19 (6), 1612-1619, 2013 | 30 | 2013 |
| Variations in common carotid artery intima-media thickness during the cardiac cycle: implications for cardiovascular risk assessment JF Polak, A Meisner, MJ Pencina, PA Wolf, RB D'Agostino Journal of the American Society of Echocardiography 25 (9), 1023-1028, 2012 | 30 | 2012 |
| RiGoR: reporting guidelines to address common sources of bias in risk model development KF Kerr, A Meisner, H Thiessen-Philbrook, SG Coca, CR Parikh Biomarker Research 3, 1-6, 2015 | 27 | 2015 |
| Methodological issues in current practice may lead to bias in the development of biomarker combinations for predicting acute kidney injury A Meisner, KF Kerr, H Thiessen-Philbrook, SG Coca, CR Parikh Kidney international 89 (2), 429-438, 2016 | 26 | 2016 |
| Urinalysis findings and urinary kidney injury biomarker concentrations GN Nadkarni, SG Coca, A Meisner, S Patel, KF Kerr, UD Patel, JL Koyner, ... BMC nephrology 18, 1-6, 2017 | 21 | 2017 |
| Pre-diagnostic circulating sex hormone levels and risk of prostate cancer by ERG tumour protein expression RE Graff, A Meisner, TU Ahearn, M Fiorentino, M Loda, EL Giovannucci, ... British Journal of Cancer 114 (8), 939-944, 2016 | 21 | 2016 |
| Case-only analysis of gene-environment interactions using polygenic risk scores A Meisner, P Kundu, N Chatterjee American journal of epidemiology 188 (11), 2013-2020, 2019 | 17 | 2019 |
| Biomarker combinations for diagnosis and prognosis in multicenter studies: Principles and methods A Meisner, CR Parikh, KF Kerr Statistical methods in medical research 28 (4), 969-985, 2019 | 17 | 2019 |
